Vendor Feedback Form_Rev.1.docx

FDA-20-RFI-1223425 – CTP Health Communication Research and Evaluation Program Vendor Feedback Form

A. Vendor/Company Name: Click or tap here to enter text.

Vendor/Company DUNS: Click or tap here to enter text.

Socioeconomic Status (check all that apply):

B. Does your company provide the services under existing Federal contract vehicle(s) (e.g., GSA schedules, Government-wide acquisition contracts (GWACs), agency-specific acquisition contracts or IDIQs) that the FDA may utilize the existing contract for the requested services?

☐ YES ☐ NO

If Yes is selected, please list the contract vehicle number(s), the current Contract End Date, the Contract End Date including all unexercised options and ordering instructions.

Click or tap here to enter text.

C. What NAICS code would your company recommend for this requirement? The FDA is considering 541910 (Marketing Research and Public Opinion Polling).

Click or tap here to enter text.

For each of the following questions, companies shall only provide responses to market research questions where they have direct knowledge and experience that is pertinent to the specific question. Each individual response to a question shall not exceed five hundred (500) words per question using 8.5” x 11” pages in single-spaced, 12-point font size in Calibri (or equivalent).

1. What previous experience does your company have evaluating small and large public health education campaigns?

2. Building on the response to question 1, please provide specific information about your company’s experience evaluating small and large public health education campaigns, including: the campaign(s) evaluated; target audience(s); campaign length/period(s); reach/geographical area(s) covered; campaign budget(s); and evaluation's metrics, methods, length, and cost.

3. What experience does your company have using media placement information, advertisement ratings, digital advertising, social media metrics as well as other data to track the effectiveness of local and/or national public health education campaigns?

4. What methods exist to effectively and accurately measure and distinguish the impact of traditional advertisements versus the impact of digital advertisements (reach and engagement), social media, public relations/earned media, and other components of FDA’s tobacco public health education campaigns on media outcomes (reach and frequency) as well as behavior change?

5. What experience does your company have evaluating large education or marketing campaigns in the commercial sector? If applicable, how would those experiences and approaches benefit FDA?

6. How would your company propose assessing the relative impact of broadcast vs. digital media buy on reach and frequency?

7. What methods exist to effectively and accurately measure the value of using influencers to deliver public health education campaign messages? Have you employed any of these methods and if so, what were the findings?

8. How would you effectively evaluate the impact of FDA’s tobacco public health education campaigns in the current media environment where tobacco users and those who are susceptible are exposed to increasing information about modified risk tobacco products and messaging about the continuum of harm?

9. With respect to targeted digital advertising, what are your companies’ capabilities for reaching and evaluating niche or hard to reach populations (e.g., young adult tobacco users who identify as Lesbian, Gay, Bisexual, or Transgender (LGBT) or rural male youth who use and/or are susceptible to using smokeless tobacco?

10. What methods exist to perform a cost-benefit analysis to evaluate the impact of (1) traditional advertisements, (2) digital advertisements, (3) social media, and (4) public relations/earned media on ad and brand awareness on FDA’s tobacco public health education campaigns?

11. Where are small businesses most active within this industry? How can their expertise best be utilized as a prime, or how could their expertise best be used as a subcontractor if you feel small businesses could not perform as the prime?

12. Does your company have any additional information not previously provided that could assist the FDA in their market research?

13. The Government anticipates making small business participation a requirement. Please provide your perspective on a minimum small business subcontracting goal. Describe what tasks are/work is appropriate and suitable to be subcontracted to small businesses. Further, explain, in detail, how your firm could meet the proposed goal and include information on the specific services that your firm would subcontract to small businesses.

14. Please offer any suggestions of how FDA can best structure contract requirements to facilitate competition by and among small business concerns.